These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 17408955)

  • 1. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.
    Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P
    Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau protein: relevance to Parkinson's disease.
    Lei P; Ayton S; Finkelstein DI; Adlard PA; Masters CL; Bush AI
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1775-8. PubMed ID: 20678581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
    Paleologou KE; Irvine GB; El-Agnaf OM
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
    Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
    Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers.
    Danzer KM; Schnack C; Sutcliffe A; Hengerer B; Gillardon F
    J Neurochem; 2007 Dec; 103(6):2401-7. PubMed ID: 17883396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
    Frasier M; Walzer M; McCarthy L; Magnuson D; Lee JM; Haas C; Kahle P; Wolozin B
    Exp Neurol; 2005 Apr; 192(2):274-87. PubMed ID: 15755545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation.
    Benussi L; Ghidoni R; Paterlini A; Nicosia F; Alberici AC; Signorini S; Barbiero L; Binetti G
    Exp Cell Res; 2005 Aug; 308(1):78-84. PubMed ID: 15904919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies.
    Shao CY; Crary JF; Rao C; Sacktor TC; Mirra SS
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):327-35. PubMed ID: 16691114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live cell imaging of cytoskeletal dynamics in neurons using fluorescence photoactivation.
    Gauthier A; Brandt R
    Biol Chem; 2010 Jun; 391(6):639-43. PubMed ID: 20370315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
    Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
    Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
    Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
    J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.
    Furukawa K; Matsuzaki-Kobayashi M; Hasegawa T; Kikuchi A; Sugeno N; Itoyama Y; Wang Y; Yao PJ; Bushlin I; Takeda A
    J Neurochem; 2006 May; 97(4):1071-7. PubMed ID: 16606366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between metals and alpha-synuclein--function or artefact?
    Brown DR
    FEBS J; 2007 Aug; 274(15):3766-74. PubMed ID: 17617226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and synergistic fibrillization of tau and alpha-synuclein.
    Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM
    Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.